These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 8330650

  • 1. Design and validation of a clinically applicable culture procedure for the generation of interleukin-2 activated natural killer cells in human bone marrow autografts.
    Klingemann HG, Deal H, Reid D, Eaves CJ.
    Exp Hematol; 1993 Aug; 21(9):1263-70. PubMed ID: 8330650
    [Abstract] [Full Text] [Related]

  • 2. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA, Pekle K, Gazzola MV, Collins NH, Bourhis JH, Gillio A.
    J Immunol; 1989 Nov 15; 143(10):3241-9. PubMed ID: 2809200
    [Abstract] [Full Text] [Related]

  • 3. Comparison of natural killer activity of human bone marrow and blood cells in cultures containing IL-2, IL-7 and IL-12.
    Wong EK, Eaves C, Klingemann HG.
    Bone Marrow Transplant; 1996 Jul 15; 18(1):63-71. PubMed ID: 8831997
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-2 activation of human bone marrow in long-term cultures: an effective strategy for purging and generation of anti-tumor cytotoxic effectors.
    Verma UN, Bagg A, Brown E, Mazumder A.
    Bone Marrow Transplant; 1994 Feb 15; 13(2):115-23. PubMed ID: 8205079
    [Abstract] [Full Text] [Related]

  • 5. Culture of normal and leukemic bone marrow in interleukin-2: analysis of cell activation, cell proliferation, and cytokine production.
    Klingemann HG, Neerunjun J, Schwulera U, Ziltener HJ.
    Leukemia; 1993 Sep 15; 7(9):1389-93. PubMed ID: 8371589
    [Abstract] [Full Text] [Related]

  • 6. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D, Goan SR, Junghahn I, Winkler J, Fichtner I, Hermann M, Becker M, de Lima-Hahn E, Henschler R.
    Stem Cells; 1999 Sep 15; 17(3):152-61. PubMed ID: 10342558
    [Abstract] [Full Text] [Related]

  • 7. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
    Bhatia R, McGlave PB, Miller JS, Wissink S, Lin WN, Verfaillie CM.
    Exp Hematol; 1997 Aug 15; 25(9):980-91. PubMed ID: 9257812
    [Abstract] [Full Text] [Related]

  • 8. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood.
    Klingemann HG, Wong E, Maki G.
    Biol Blood Marrow Transplant; 1996 May 15; 2(2):68-75. PubMed ID: 9118301
    [Abstract] [Full Text] [Related]

  • 9. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.
    Exp Hematol; 1995 Dec 15; 23(14):1530-4. PubMed ID: 8542943
    [Abstract] [Full Text] [Related]

  • 10. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
    Miller JS, Tessmer-Tuck J, Pierson BA, Weisdorf D, McGlave P, Blazar BR, Katsanis E, Verfaillie C, Lebkowski J, Radford J, Burns LJ.
    Biol Blood Marrow Transplant; 1997 Apr 15; 3(1):34-44. PubMed ID: 9209739
    [Abstract] [Full Text] [Related]

  • 11. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.
    Clin Cancer Res; 1998 Nov 15; 4(11):2859-68. PubMed ID: 9829753
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-12 (IL-12) alone or in synergistic combination with IL-2 for in vitro activation of human bone marrow: differential effects at different time points.
    Verma UN, Mazumder A.
    Bone Marrow Transplant; 1995 Sep 15; 16(3):365-72. PubMed ID: 8535308
    [Abstract] [Full Text] [Related]

  • 13. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor.
    Herrera C, García-Pérez MJ, Ramirez R, Martín C, Alvarez MA, Martinez F, Gómez P, García-Castellano JM, Torres A.
    Bone Marrow Transplant; 1997 Mar 15; 19(6):545-51. PubMed ID: 9085733
    [Abstract] [Full Text] [Related]

  • 14. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM, Tafuri A, Fortuna A, Catani L, Rondelli D, Ratta M, Tura S.
    Bone Marrow Transplant; 1998 Dec 15; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [Abstract] [Full Text] [Related]

  • 15. Antitumor activity, growth, and phenotype of long-term IL-2 cultures of human NK and T lymphocytes.
    Fuchshuber PR, Lotzová E, Pollock RE.
    Lymphokine Cytokine Res; 1991 Apr 15; 10(1-2):51-9. PubMed ID: 1651770
    [Abstract] [Full Text] [Related]

  • 16. [Effects of FPIL6/IL2 on the differentiation and proliferation of lymphoid in the ML-IC assay].
    Fan EJ, Song JM, Xu SR, Zhao CH.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb 15; 24(1):30-5. PubMed ID: 12905836
    [Abstract] [Full Text] [Related]

  • 17. Effect of flt3 ligand on in vitro growth and expansion of colony-forming bone marrow cells from patients with aplastic anemia.
    Wodnar-Filipowicz A, Chklovskaia E, Manz CY, Lyman SD, Nissen C.
    Exp Hematol; 1997 Jul 15; 25(7):573-81. PubMed ID: 9216732
    [Abstract] [Full Text] [Related]

  • 18. Generation of natural killer cells from long-term cultures of mouse bone marrow.
    Vecchini F, Delfino D, Patrene KD, DeLeo A, Lu L, Herberman RB, Boggs SS.
    Nat Immun; 1993 Jul 15; 12(1):1-16. PubMed ID: 8431659
    [Abstract] [Full Text] [Related]

  • 19. IL-2-activated cord blood mononuclear cells.
    Derzic S, Slone V, Sender L.
    Cytotherapy; 2005 Jul 15; 7(5):408-16. PubMed ID: 16236630
    [Abstract] [Full Text] [Related]

  • 20. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL, Rebel VI, Lemieux ME, Helgason CD, Lansdorp PM, Eaves CJ.
    Exp Hematol; 1996 Feb 15; 24(2):185-94. PubMed ID: 8641340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.